业界动态国内医卫资讯

阿松德西安会改变卒中二级预防吗?

Medscape News · 2026-11-11 21:38

摘要

随着首个凝血因子XIa抑制剂现已获得美国食品药品监督管理局(FDA)批准,卒中专家评估其改变卒中二级预防的潜力——以及可能限制其应用的挑战。Medscape Medical News

English
Will Asundexian Change Secondary Stroke Prevention?

With the first factor XIa inhibitor now FDA-approved, stroke experts weigh its potential to transform secondary stroke prevention — and the challenges that could limit its adoption. Medscape Medical News

内容仅供参考,不构成诊疗建议,不能替代执业医师的诊断。

← 返回元界